
Episode 23: A Between the Biotech Waves conversation with Jim Birchenough, Vice Chair of Wells Fargo Biopharmaceutical Inv Banking
Between the Biotech Waves
00:00
Is 2023 Going to Be a Good Year?
I'm optimistic about 23 also, but I'd hoped, you know, that Q4 of 22, that we would have started to see some of this playing out. And so, it's really going to be this early part of Q1, are we really going to see people getting more active? Are we going to see data points that are going to come through that will continue to drive overall interest in the market? And can companies continue to actually differentiate themselves? Because, you talk about what 650 companies out there, that's a lot of companies being able to differentiate yourself and rise above what is a lot of chatter and background noise.
Transcript
Play full episode